Maeda Tomoya, Furusawa Chikara
Laboratory of Microbial Physiology, Research Faculty of Agriculture, Hokkaido University, Kita 9, Nishi 9, Kita-ku, Sapporo 060-8589, Japan.
Center for Biosystems Dynamics Research, RIKEN, 6-2-3 Furuedai, Suita 565-0874, Japan.
Antibiotics (Basel). 2024 Jan 18;13(1):94. doi: 10.3390/antibiotics13010094.
Laboratory evolution studies, particularly with , have yielded invaluable insights into the mechanisms of antimicrobial resistance (AMR). Recent investigations have illuminated that, with repetitive antibiotic exposures, bacterial populations will adapt and eventually become tolerant and resistant to the drugs. Through intensive analyses, these inquiries have unveiled instances of convergent evolution across diverse antibiotics, the pleiotropic effects of resistance mutations, and the role played by loss-of-function mutations in the evolutionary landscape. Moreover, a quantitative analysis of multidrug combinations has shed light on collateral sensitivity, revealing specific drug combinations capable of suppressing the acquisition of resistance. This review article introduces the methodologies employed in the laboratory evolution of AMR in bacteria and presents recent discoveries concerning AMR mechanisms derived from laboratory evolution. Additionally, the review outlines the application of laboratory evolution in endeavors to formulate rational treatment strategies.
实验室进化研究,尤其是对[具体对象未给出]的研究,已经为深入了解抗菌药物耐药性(AMR)机制提供了宝贵的见解。最近的研究表明,随着抗生素的反复暴露,细菌群体将发生适应性变化,最终对药物产生耐受性和耐药性。通过深入分析,这些研究揭示了不同抗生素之间趋同进化的实例、耐药性突变的多效性影响以及功能丧失突变在进化过程中所起的作用。此外,对多种药物组合的定量分析揭示了协同敏感性,发现了能够抑制耐药性产生的特定药物组合。这篇综述文章介绍了细菌中AMR实验室进化所采用的方法,并阐述了从实验室进化中获得的有关AMR机制的最新发现。此外,该综述还概述了实验室进化在制定合理治疗策略方面的应用。